🟢 $TLX +7.72%

- Share price increased following the announcement of a strategic partnership with US-based biotechnology company Regeneron.

#TelixPharmaceuticals

Illuccix therapy gets approval in the UK - PharmaTimes Imaging agent to improve prostate cancer detection

#medicalimaging #MolecularImaging #ImagingSciences #Illuccix #Illuccixtherapy #Imagingagent #prostatecancerdetection #TelixPharmaceuticals #Telix #XielLimited #diagnosticradiology #MHRA #MarketingAuthorisationApplication #prostatecancer #PSMAPETsupplyshortages
pharmatimes.com/news/illucci...